Exclusive: Cardiometabolic biotech gets $57.5M Series B, with help from Cytokinetics
Summary
A biotech in\xadcu\xadbat\xaded by RA Cap\xadi\xadtal has se\xadcured a $57.5 mil\xadlion Se\xadries B to be\xadgin a mid-stage tri\xadal for its car\xaddio drug this quar\xadter and Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected